| Course | PA 536 Behavioral Medicine II |
|---|---|
| Week | 8 |
| Paper type | Maintenance and taper plan |
| Length | About 780 words, 5 pages |
| Format | APA 7 student paper |
| School | Chamberlain University |
| Program | Master of Physician Assistant Studies (MPAS) |
| Updated | October 2026 |
Free sample paper for PA 536 Week 8
Maintenance and Taper Plan for D.K. After a Third Episode: Counting From the Day of Remission, Two Years Before Any Reduction, Aripiprazole Off First and a Way Back That Needs No Appointment
Student Name
Chamberlain University
PA 536: Behavioral Medicine II
Instructor Name
Month Day, Year
Maintenance and Taper Plan for D.K. After a Third Episode: Counting From the Day of Remission, Two Years Before Any Reduction, Aripiprazole Off First and a Way Back That Needs No Appointment
Counting From the Right Day
This plan counts from August 18, 2026, the first of two consecutive visits with a PHQ-9 below 5, not from April 16, when fluoxetine was first taken, or June 23, when aripiprazole was added. The difference matters: counting from the start of treatment would make the earliest reduction four months sooner than counting from remission, and the relapse risk in those months is the risk this plan exists to manage.
How Long, Argued From This Person
D.K. has had three episodes of major depression, at 29, 35 and 41. Each recurrence raises the chance of the next. In a large primary care trial, among adults well enough to think about coming off treatment, relapse within a year was 56 percent in those who tapered off and 39 percent in those who stayed on their antidepressant (Lewis et al., 2021). D.K. also has a concrete cost of relapse that many patients do not: the last episode showed that depression erodes insulin dosing within weeks. For these reasons the plan continues fluoxetine for at least two years from remission, to August 2028, and revisits the question then rather than setting an end date now.
The Order of Reductions
Aripiprazole was added for a partial response and carries the weight and lipid cost. It is reduced first, after six months of remission, in February 2027, by stopping the 2 mg dose after a two-week period at 1 mg, with no change to fluoxetine at the same time. Fluoxetine continues unchanged until at least August 2028. If a fluoxetine reduction is then chosen, it will use gradual steps spaced weeks apart and becoming smaller as the dose falls, the approach argued for by Horowitz and Taylor (2019), rather than a fixed short taper. No dose numbers for those later steps are set now.
If restlessness or weight gain had forced aripiprazole off earlier, the order would be the same: the add-on goes first and the base medicine stays.
Days After a Step, Weeks After That
Symptoms in the days after a reduction, such as dizziness, irritability, poor sleep or a flu-like feeling, are more likely to be withdrawal effects. Fluoxetine's long half-life makes these less common, but aripiprazole has its own. Low mood, loss of interest and the return of skipped boluses that build over two to six weeks are more likely to be the illness returning. The plan treats them differently. Withdrawal effects in the first week call for a phone check and, if troublesome, a return to the previous dose for two weeks before a smaller step. A pattern building over weeks calls for a PHQ-9 and a visit.
Who Would Notice
Three people and one device. D.K. completes a PHQ-9 by portal every four weeks for three months after each reduction. D.K.'s partner has agreed to say so if D.K. stops going to Thursday darts. The PA reviewing the pump download at each three-month diabetes visit will check the dinner bolus count, which fell early in the last episode and is the best warning sign available for this person. A drop below five dinner boluses a week for two weeks running prompts a call.
A Route Back Without an Appointment
If D.K. or the partner thinks things are slipping, D.K. can send a portal message or call the nurse line, and the nurse may restart the last effective dose that day under a standing note written into this plan, with a visit within two weeks. No one has to wait for the next scheduled appointment to go back to what worked.
What Is Written Down
This plan is in the chart under the problem list entry for recurrent depression, in D.K.'s after-visit summary and in a portal message D.K. can reread. Each step carries its date, the condition for taking it and the condition for stopping or reversing it.
The plan also states what it does not decide. It does not set an end date for fluoxetine, does not promise that D.K. will come off medication, and does not cover a fourth episode if one occurs; that would need a new plan written at the time, starting again from whatever is known then about what worked.
References
Horowitz, M. A., & Taylor, D. (2019). Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, 6(6), 538-546. https://doi.org/10.1016/S2215-0366(19)30032-X
Lewis, G., Marston, L., Duffy, L., Freemantle, N., Gilbody, S., Hunter, R., Kendrick, T., Kessler, D., Mangin, D., King, M., Lanham, P., Moore, M., Nazareth, I., Wiles, N., Bacon, F., Bird, M., Brabyn, S., Burns, A., Clarke, C. S., . . . Lewis, G. (2021). Maintenance or discontinuation of antidepressants in primary care. New England Journal of Medicine, 385(14), 1257-1267. https://doi.org/10.1056/NEJMoa2106356
PA 536 Week 8 instructions, in plain terms
The final week asks for a plan covering how long treatment continues after a person becomes well and how any reduction would happen. Name the date the plan counts from, and make it the date of remission rather than the start of treatment, explaining the difference. Argue the length of maintenance from this person's own history, citing evidence on relapse. If more than one medicine is involved, set the order of reductions and keep them apart in time. Describe what symptoms in the days after a step mean compared with a pattern building over the following weeks, and how each would be handled. The instructions place weight on monitoring: who would notice if things go wrong, and how. Finally, give the person a way back to effective treatment that does not depend on waiting for the next booked appointment.
How this PA 536 Week 8 example is built
The plan's first section fixes August 18, 2026, the first of two PHQ-9 scores under 5, as its anchor and explains that counting from April or June would bring reductions forward. The duration section uses D.K.'s three episodes, the speed at which depression eroded insulin dosing and the ANTLER results (Lewis et al., 2021) to keep fluoxetine at least to August 2028. The order section takes aripiprazole off first in February 2027, through a short period at 1 mg, with fluoxetine unchanged, and points to gradual hyperbolic steps for any later fluoxetine reduction (Horowitz and Taylor, 2019). A section separates dizziness and irritability in the first days from mood and missed boluses building over two to six weeks. The monitoring section names a portal PHQ-9, D.K.'s partner, darts attendance and the pump's dinner bolus count, and a standing note lets the nurse restart the last effective dose the same day.
PA 536 Week 8 rubric: what full points look like
In this plan the first deduction is counting from the wrong day. A plan that runs its months from the start of treatment, rather than from remission, loses most of the available credit before the rest is read. Nearly as costly is a reduction with nobody watching for its results. Graders then look for withdrawal symptoms in the days after a step kept distinct from a relapse pattern over weeks, each with its own response. Duration must be argued from this person's history and cited relapse evidence, not from a standard number. Where two medicines are involved, reducing them separately and in a stated order earns credit. A route back that needs no appointment is graded as a safety feature. Clear documentation of where the plan lives, and APA citations, complete the scoring.
PA 536 Week 8 help: mistakes that cost points
The most common reason this plan is returned is a duration counted from the first prescription, which shortens maintenance without anyone noticing. Another is a neat taper schedule with no monitoring, so nobody would learn it was failing until the next visit months later. A third is treating every symptom after a step as relapse and restarting full treatment unnecessarily. If your case involves a single medicine, a first episode or a person who wants to stop quickly, send the history and your section's prompt; a plan written for you would set its anchor at remission, argue the duration from that history, order any reductions, separate withdrawal from relapse, name who watches and give a route back. If your course patient has a monitoring signal of their own, such as a sleep tracker or work attendance, it can serve the role the pump plays in this sample.
Get a PA-536 Week 8 example written to your instructions
Send the assignment, the rubric and the case as your section issued it, and say whether the plan has to state a stopping date outright or argue a range. A custom PA-536 Week 8 plan is written to those and returned inside 24-48h, the first one free. Nobody you have looked after appears in it; the person is put together for the week.
More PA 536 papers and MPAS samples
- PA 536 Week 1: Treatment Target Post
- PA 536 Week 2: Antidepressant Selection Memo
- PA 536 Week 3: Antidepressant Trial Appraisal
- PA 536 Week 4: Switch Versus Augment Brief
- PA 536 Week 5: Metabolic Monitoring Schedule
- PA 536 Week 6: Therapy Modality Brief
- PA 536 Week 7: Medical Comorbidity Review
- PA 534 Week 8: Adolescent Confidentiality Brief
- PA 533 Week 8: Well-Woman Visit Outline
- PA 532 Week 8: Complication Timeline Analysis
- PA 531 Week 8: Return Precautions Sheet
PA 536 Week 8 questions, answered
The case never says when the person became well.
Then the plan establishes the best date it can and says how it got there, which is a graded move rather than a workaround. Use whatever the material gives: a visit where something was recorded as settled, a return to work, a report from somebody who knows the person. Name the date, name its evidence, and say how far the whole plan moves if that date proves a month out.
Does the plan have to finish with stopping?
Not in most sections. Continuing, with the reasoning for continuing written out and a point set for reconsidering it, is a legitimate conclusion and often the better document when the history supports it. What loses marks is the unargued version, where the plan continues by default and nothing anywhere says for how long or what would change the answer.
What if the person wants to move faster than the plan does?
That belongs in the document rather than around it. Record what they want and why, say what the faster version would cost in terms of what could be told apart afterward, and write the plan so their preference is visible in it rather than overruled silently. Rubrics in this week often carry an element on preference, and plans that argue past it lose that row outright.
Where can I find a free PA 536 Week 8 sample paper?
A complete PA 536 Week 8 maintenance and taper plan after a third depressive episode, counted from remission with a route back by nurse line, is on this page.
Why does the PA 536 Week 8 sample stop aripiprazole before fluoxetine?
Aripiprazole was added for a partial response and carries weight and lipid costs, and reducing one medicine at a time lets any change in mood be traced to one step.